Experimental drug doubles one-year survival in pancreatic cancer

1 month ago 11

A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.

Read Entire Article

Experimental drug doubles one-year survival in pancreatic cancer

Related

Meet the Artemis III Astronauts Preparing for NASA’s Boldest Moon Mission Yet

Scientists Develop a New Way To Measure Gravitational Waves in the Expanding Universe

MIT’s New Dual-Mode Rocket System Could Send Tiny Satellites to Mars